Ingredients: Angelica Archangelica L., Radix Astragali, Solanum Nigrum L., Herba Solani Lyrati.

Actions and Indications: It is a supplementary drug for lung cancer patients undergoing chemotherapy. Its action helps to improve the assessment score of clinical symptoms and physical strength. It has also an improving effect on the NK and CD4 cells of the immunity index, and may lessen the reaction due to chemotherapy such as lowering of the peripheral hemogram, liver and kidney injury as well as nausea and vomiting, hair loss among others.

Dosage and Administration:

Orally, 4 tablets per dose, 3 times a day.  This drug should be used whilst undergoing chemotherapy.  A period consists of 4 weeks, and a treatment course consists of 2 periods.

Specifications: 0.65g/tablet*48tablets/box*160boxes/carton.

Summarize: Zilongjin Tablet is a product of the perfect integration of Chinese traditional medicine with modern medicine.  It is a joint development of the Clinical Oncology Institute of the Bejing University and Longshunrong Pharmaceutical Factory, and was approved by the State Pharmaceutical Product Supervision Administration to manufacture as an anti-tumor new drug and has a patent to it.  Currently, it is the first natural anti-tumor medicinal product within China that has systematically completed the cell molecule biological basis such as gene, cell cycle protein and signal channel, and can significantly enhance the efficacy of actinotherapy and chemotherapy, and effictively control the development of the tumor.  This drug has highly effective protective and repairing functions, and may assist in the completion of actinotherapy and chemotherapy.  Additionally, it significantly improves the clinical symptoms, upgrades quality of life.  It has good safety and significantly reduces the toxicity of actinotherapy and chemotherapy.